ghk-cu peptide structure | C28H48CuN12O8 | CID 133697840 The Effect of the Human
Description
doi:10.1016/j.amjoto.2021.103151
doi:10.2147/DDDT.S284163 Hsieh MJ, Liu HT, Wang CN, et al
Wang, Zhaowei
Stereochemical modifications at key positions (e.g., C3, C20) can switch compounds between agonist, antagonist, and receptor-selective profiles, enabling targeted development of G-protein-biased ligands with minimized -arrestin-2 recruitment
